SCHEMBL23869287

SCHEMBL23869287

c1ccc(-c2nc(-c3ccc(-c4cccc5ccccc45)cc3)nc(-c3ccc4c(c3)[Si](c3ccccc3)(c3ccccc3)c3c-4ccc4ccccc34)n2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.39
ALDH1A1 P00352 5/20 0.39
HPGD P15428 4/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
KDM4E B2RXH2 3/20 0.39
MAPK1 P28482 2/20 0.39
HSD17B10 Q99714 2/20 0.39
TP53 P04637 1/20 0.39
TSHR P16473 1/20 0.39
NFKB1 P19838 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
ATM Q13315 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
CA12 O43570 2/20 0.36
CA1 P00915 2/20 0.36
CA2 P00918 2/20 0.36
CA9 Q16790 2/20 0.36
TNF P01375 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23869288 0.90 ALDH1A1 (0.41) MAPTALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL23868752 0.90 SMN1; SMN2 (0.35) MAPTALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL23869097 0.89 SMN1; SMN2 (0.36) MAPTALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL23869289 0.89 SMN1; SMN2 (0.36) MAPTALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL23868835 0.89 ALDH1A1 (0.40) MAPTALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL23869244 0.86 MAPT (0.38) MAPTALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL23868949 0.86 CA12 (0.40) MAPTALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL23868683 0.86 KDM4E (0.39) MAPTALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL23869285 0.85 KDM4E (0.41) MAPTALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL26278656 0.85 ALDH1A1 (0.37) MAPTALDH1A1HPGDSMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210300951-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2021-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210300951-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE OR10J3, OCIAD2, OCIAD1 MAPT 1051/4885ALDH1A1 201/4885HPGD 2223/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.